Genome Senquencing of Lymphomas Progressing   1 comment

This is very good news, it seems to me.

Researchers at the Mayo Clinic have completed the first genome-wide sequencing of peripheral T cell lymphomas, which will allow doctors to delve into this cancer of the immune system that account for 12% of all non-hodgkin’s lymphomas and are among the most deadly. Fewer than 35 percent of patients live five years beyond diagnosis. Andrew Feldman was the lead investigator and said of the breakthrough:

“Every time I diagnose a peripheral T-cell lymphoma, I know that two out of three patients will succumb to that lymphoma,” says Dr. Feldman. “That’s a very unsatisfying feeling, and I hope that our research can help change those statistics.”

How little, in fact, doctors understand about this type of cancer is summed up in the name of the most-common form of the disease:

“The most common type of T-cell lymphoma is called ‘not otherwise specified.’ It’s basically a wastebasket diagnosis because we don’t understand enough about the specific genetic abnormalities to be able to pinpoint subtypes of T-cell lymphomas that might trigger different treatments by the treating oncologist,” says Dr. Feldman.

Let’s hope his work will lead to better days ahead.


Posted August 7, 2012 by lymphomactivist in NHL, Research

Tagged with , , ,

One response to “Genome Senquencing of Lymphomas Progressing

Subscribe to comments with RSS.

  1. Pingback: The Lymphomas | MEDINFOPAGES.COM

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: